VTVT
Closed
Vtv Therapeutics Inc
13.54
-0.70 (-4.92%)
Last Update: 17 Oct 2024 23:00:00
Yesterday: 14.24
Day's Range: 13.54 - 13.54
Send
sign up or login to leave a comment!
When Written:
0.7447
vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company that focuses on developing treatments for various diseases such as diabetes, Alzheimer's disease, and inflammatory disorders. The company's lead product candidate is TTP399, an oral small molecule drug that is being developed for the treatment of type 1 and type 2 diabetes. vTv Therapeutics also has a pipeline of other drug candidates, including a treatment for Alzheimer's disease and a treatment for inflammatory disorders. The company was founded in 2015 and is headquartered in High Point, North Carolina.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!